Introductory rate of $570 expires 8/18/10. Save $150 off the regular rate of $720. Click the sample link below to view the complete table of contents and select pages.

Breakthrough advancements in medical devices and convergent technologies for the development of next-generation products have improved patient monitoring, safety and outcomes, reduced recovery time, and prevented costly complications.

Many U.S.-based medical device and technology companies are developing partnerships on a global scale to pursue innovation and implement strategies that will allow them to expand into emerging markets. Corporate managers believe that this strategy will offset the impact of diminishing VC investment due to almost-certain changes regarding the U.S. approval pathway for medical devices and the proposed innovation tax that skeptics fear may stifle innovation, decrease job opportunities, and limit solutions available to patients.

This publication features the world’s leading medical device and technology companies. This report provides an authoritative and complete overview of the largest manufacturers of medical devices and technologies around the globe in a convenient and concise format. Included are rankings of the largest device companies based on 2009 revenue and a corporate profile of each entity.

Company data featured in this edition include:
• Company overview
• Financials for recent years
• Rankings by revenue
• Leadership personnel
• Recent acquisitions
• Significant subsidiaries
• Medical specialties/sectors
• Key products

Medical devices that would have been considered science fiction just a few years ago are quickly becoming the standard of care. Over the next few years, advances in medical device technology will revolutionize the way treatments are administered.

Popular trends in medical device innovation include combination devices of drugs and biologics, nanotechnology, use of less-invasive surgeries and devices, and IT/wireless technology for hospitals. In the next few years, neurology, cardiovascular and orthopedics represent promising technological opportunities due to an aging population. Industry segments such as oncology and cardiology remain more immune to market dynamics and changes.

Many medical device companies expect that healthcare legislation could have a negative impact on the industry during 2010. The largest challenge will be an increase in FDA regulations for oversight as well as compliance. However, this legislation will not stop the industry from generating solid revenue growth.

This special report about medical device approvals includes the following information:

– A recap and analysis of the promising and anticipated medical devices approved by the U.S. Food and Drug Administration via the Premarket Approval (PMA) process during 2009 and early 2010.

– A complete listing of the medical devices cleared for marketing by FDA via the 510(k) Premarket Notification process in 2009, including the following details for each entry:
• Product code
• Product description
• Registration number
• Company
• Decision date